ReviewDrug safety2016
Quantitative Risk-Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease.
William E BennettPubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it